scPharmaceuticals Inc. (SCPH)
NASDAQ: SCPH · Real-Time Price · USD
2.775
-0.265 (-8.72%)
At close: Mar 28, 2025, 4:00 PM
2.832
+0.057 (2.05%)
After-hours: Mar 28, 2025, 7:56 PM EDT
scPharmaceuticals Revenue
In the year 2024, scPharmaceuticals had annual revenue of $36.33M with 167.28% growth. scPharmaceuticals had revenue of $12.15M in the quarter ending December 31, 2024, with 99.31% growth.
Revenue (ttm)
$36.33M
Revenue Growth
+167.28%
P/S Ratio
3.40
Revenue / Employee
$267,147
Employees
136
Market Cap
139.54M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionSCPH News
- 9 days ago - scPharmaceuticals Inc. (SCPH) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 9 days ago - scPharmaceuticals Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 16 days ago - scPharmaceuticals to Announce Fourth Quarter and Full Year 2024 Financial Results on Wednesday, March 19, 2025 - GlobeNewsWire
- 22 days ago - scPharmaceuticals Announces FDA Approval of Supplemental New Drug Application Expanding the FUROSCIX® Indication to Include the Treatment of Edema in Patients with Chronic Kidney Disease - GlobeNewsWire
- 4 weeks ago - scPharmaceuticals Announces Participation in Two Upcoming Investor Conferences - GlobeNewsWire
- 7 weeks ago - scPharmaceuticals to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference - GlobeNewsWire
- 2 months ago - scPharmaceuticals Provides Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 4 months ago - scPharmaceuticals Inc. (SCPH) Q3 2024 Earnings Call Transcript - Seeking Alpha